Dr. Scott is a Professor in the Department of Pathology at Stanford University and Director of the Stanford Medicine Clinical Genomics Laboratory, where he oversees genomic test innovation and implementation. He is certified by the ABMGG in both Clinical Molecular Genomics and Cytogenetics, and his translational research interests include human genomics, pharmacogenomics, cytogenomics, long-read sequencing, and the implementation of genomic medicine. Dr. Scott is on the steering committees of the CPIC and PharmVar consortia; and previously or currently is a member of the AMP Pharmacogenomics Working Group, IUPHAR, and other national consortia focused on translational genomic medicine (ClinGen, eMERGE, IGNITE, UDN, GREGoR). He has published over 170 peer-reviewed manuscripts and book chapters on human genomics and is Co-PI of the Stanford Catalyst-funded SPIRA program, which included the development, validation, and clinical implementation of a long-read HiFi pharmacogenomics sequencing panel at Stanford Health Care.